Recap of Wednesday’s Biotech Catalysts – End of The Day Summary
IDEAYA Biosciences (NASDAQ:IDYA) has entered into a clinical trial collaboration and supply agreement with Amgen Inc. to evaluate…
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers
Talis Biomedical (NASDAQ:TLIS) shares moved upwards by 10.6% to $0.94 during Tuesday's after-market session. The company's market cap stands at $25.0 million.
This Low-Float Stock Jumps Around 148%; Here’s 64 Biggest Movers From Yesterday
Gainers
United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market.
Palisade Bio Receives Notice Of Allowance For U.S. Patent Titled ‘ADMINISTRATION OF SERINE PROTEASE INHIBITORS TO THE STOMACH (FOR THE TREATMENT OF SHOCK & POTENTIAL MULTI-ORGAN FAILURE DUE TO SHOCK)’
https://patentcenter.uspto.gov/#!/applications/16989148/ifw/docs
Palisade Bio Provides Business Outlook And Highlights Expected Near-Term Pipeline Advancements
Palisade Bio (NASDAQ:PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today provided a business outlook and outlined its